CClinicalTrials.gg
RecruitingNCT02851043Updated Nov 21, 2025

Non-Invasive Respiratory Monitor

An interventional study of pneuRIP (breathing with resistance) and Respitrace system (Carefusion) (breathing without resistance) in Neuromuscular Diseases and Healthy Volunteers, sponsored by Nemours Children's Clinic. Recruiting at 1 site in United States. Open to participants aged 11 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-21.

Sponsored by Nemours Children's Clinic · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 1 year 11 months after the study started (first participant enrolled Aug 2014, registered Jul 2016).
  • Started Aug 2014; still recruiting 12 years 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Non-randomized
Ages
11 Years to 17 Years
Sex
All
01

Study summary

This study will clinically evaluate a newly developed respiratory monitor - pneuRIP. The pneuRIP uses Respiratory Inductance Plethysmography (RIP) bands to measure key breathing indices non-invasively. This study compares the pneuRIP to an existing Respitrace system (Carefusion, Yorba Linda CA). 10 normal children and 10 children with breathing difficulties will be monitored with both systems.

Read the detailed description

Firstly, ten healthy children will participate in a trial to evaluate the pneuRIP. They will be fitted with the bands around their abdomen and chest. The pneuRIP will be connected to the bands through electrodes. Breathing is then measured wirelessly with an iPad. They will be asked to lie down. They are asked to breath normally then asked to breath with a resistive elements to place in their mouth. The resistive elements makes it difficult to breath (similar to breathing through a straw). They will breathe for 3 minutes for both conditions as we record their breathing with the pneuRIP and the Respitrace. These data will be compared.

Secondly, A group of 10 subjects from the outpatient muscle clinic will be fitted with the chest and abdomen bands. The Respitrace monitor and the pneuRIP will record their breathing patterns. Data from the two systems will then be compared.

02

Conditions studied

  • Neuromuscular Diseases
  • Healthy Volunteers
03

In context

Neuromuscular Diseases

300 studies on the registry are indexed under Neuromuscular Diseases; 87 are open to participants now.

This study's planned enrollment of 20 is below the median of 32 across 168 interventional studies indexed under Neuromuscular Diseases.

Browse Neuromuscular Diseases studies →

Lead sponsor

Nemours Children's Clinic is the lead sponsor of 127 studies on the registry; 27 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy volunteers
  • Neuromuscular disease subjects with mild breathing difficulty
  • Capable of following verbal instructions

Exclusion criteria

Exclusion Criteria:

  • Severe breathing difficulties
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    pneuRIP(breathing with resistance)

    Testing the subjects breathing with resistance

    Device: pneuRIP (breathing with resistance) · Device: Respitrace system (Carefusion) (breathing without resistance)

  • No intervention
    Respitrace system (Carefusion) (breathing without resistance)

    Testing subjects breathing without resistance

Interventions

  • DevicepneuRIP (breathing with resistance)

    subjects are given a resistance element to breath through

  • DeviceRespitrace system (Carefusion) (breathing without resistance)

    subjects are asked to breath normally

06

What researchers measure

Primary outcomes

  1. Breathing rate

    The breathing rate is measured by two different monitors

    Time frame: Immediately after test

Secondary outcomes

  1. Labored breathing Index

    The labored breathing index is measured by two different monitors

    Time frame: Immediately after test

  2. Phase Difference

    The phase difference between the pneuRIP and Respitrace is measured by two different monitors

    Time frame: Immediately after test

  3. Percent rib cage

    The percentage of breathing performed by the rib cage is measured by two different monitors

    Time frame: Immediately after test

07

Study locations

1 of 1 sites recruiting
  • Nemours/A.I. duPont Hospital for Children
    Wilmington, Delaware 19899, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02851043
Lead sponsor
Nemours Children's Clinic
Responsible party
Tariq Rahman (Principal Research Engineer, Nemours Children's Clinic) — Principal investigator
First posted
Aug 1, 2016
Start date
Aug 2014
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Nov 21, 2025

Study contacts

Tariq Rahman, PhD
Contact
trahman@nemours.org
302 651 6831
Thomas Shaffer, PhD
principal investigator · Nemours

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion